Nuvista Pharmaceuticals Private Limited

Nuvista Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24304TG2017PTC115996 Incorporated 20 March 2017 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2023
₹10.25 Cr
▲ 4% YoY
Net profit · FY 2023
₹7.81 Lakh
Net margin 0.8%
EBITDA · FY 2023
₹15.81 Lakh
EBITDA margin 1.5%
Authorised capital
₹1.9 Cr
Registered with MCA
Paid-up capital
₹1.9 Cr
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹95 Lakh
Company age
9 yrs
Est. 2017
Employees · EPFO
24
Provident fund records

About Nuvista Pharmaceuticals Private Limited

Data last updated:

Nuvista Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC115996. Its GSTIN is 36AAFCN5519F1ZH (Telangana).

The company has an authorised share capital of ₹1.9 Cr and a paid-up capital of ₹1.9 Cr. It is led by directors including Surya Rao Yechuri (Managing Director) and Masaram Venkataiah Goud.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No 48 Phase II Ida Mallapur, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2023, the company reported a revenue of ₹10.25 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹7.81 Lakh (net margin 0.8%) and EBITDA of ₹15.81 Lakh (EBITDA margin 1.5%).

The company has about 24 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Nuvista Pharma. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹95 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24304TG2017PTC115996
Registration Number 115996
Incorporation Date 20 March 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Nuvista Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shed No 48 Phase II Ida Mallapur, Hyderabad, Telangana, India – 500076
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Nuvista Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Nuvista Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Nuvista Pharmaceuticals operates one associated brand: Nuvista Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical products are researched and manufactured through focused R&D efforts.nuvistapharma.com

Financials of Nuvista Pharmaceuticals Private Limited

FY 2025 filings available

Nuvista Pharmaceuticals Private Limited reported revenue of ₹10.25 Cr (up 4% YoY) for FY 2023.

Revenue · FY 2023
₹10.25 Cr ▲ 4%
Net profit · FY 2023
₹7.81 Lakh margin 0.8%
EBITDA · FY 2023
₹15.81 Lakh margin 1.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
EBITDA CAGR growth
1 year
▼ 53%

Revenue rose 4% in the latest year. EBITDA fell 53% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹10.25 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.81 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹7.81 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin1.5%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nuvista Pharmaceuticals Private Limited, buy the company report.

Board of directors of Nuvista Pharmaceuticals Private Limited

Nuvista Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Masaram Venkataiah GoudDirector20 Mar 20179 Years 8 MonthsCurrent
Surya Rao YechuriManaging Director20 Mar 20179 Years 8 MonthsCurrent
Sudhakara Reddy KalakotaDirector17 Sep 20215 Years 2 MonthsCurrent
Kallam Srikantha ReddyDirector20 Mar 20179 Years 8 MonthsCurrent
JakkajangreddyDirector18 May 20179 Years 6 MonthsCurrent

Auditor

Nuvista Pharmaceuticals Private Limited is audited by k bhargava ramanjaneya for the financial year 2023.

Auditor firmFinancial yearFirm registration number
k bhargava ramanjaneyaFY 2023227372

Shareholding

The shareholding of Nuvista Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nuvista Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
₹95 Lakh
Breakdown by lending institutions
Others₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Mar 2024100889675Others₹50 LakhOpen
21 Aug 2018100202194Others₹95 LakhSatisfied

To see the full charge records of Nuvista Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Nuvista Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 60 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
Bio-Leo Analytical Labs India Private Limited
Nuvista Pharmaceuticals Private Limited
Rite-Aid Labs Private Limited
an individual supplier
an individual supplier

To see the full MSME payment records of Nuvista Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Nuvista Pharmaceuticals Private Limited has a workforce of 24 employees on its EPFO records as of Nov 2025, across 1 active EPFO establishment.

Employee count
24
Active EPFO establishments
1
Employee growth
-4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-2624
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22

To see the full employee and EPFO history of Nuvista Pharmaceuticals Private Limited, buy the company report.

GST

Nuvista Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAFCN5519F1ZHTelanganaActive12 Sep 2017

To see the full GST registrations and return filing status of Nuvista Pharmaceuticals Private Limited, buy the company report.

Recent activity

Nuvista Pharmaceuticals Private Limited has 7 board changes on record since 2017: 5 appointments and 2 cessations. The latest: Sudhakara Reddy Kalakota was appointed as Director on 17 Sep 2021.

AGM
Nuvista Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nuvista Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 21 Aug 2018 via Charge ID 100202194 with Others was fully satisfied on 26 Mar 2024.
Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100889675 was registered on 15 Mar 2024.
Appointed
Sudhakara Reddy Kalakota was appointed as Director.
Ceased
Manjula Kotha ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100202194 was registered on 21 Aug 2018.
Ceased
Saira Siddiqui ceased to be Director.
Appointed
Jakkajangreddy was appointed as Director.
Appointed
Kallam Srikantha Reddy was appointed as Director.
Appointed
Masaram Venkataiah Goud was appointed as Director.
Appointed
Surya Rao Yechuri was appointed as Managing Director.

1 earlier event is in the company report.

Frequently asked questions

Nuvista Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2017 (9+ years old) and is registered under CIN U24304TG2017PTC115996.

Nuvista Pharmaceuticals has 5 current directors:

The latest financial statements of Nuvista Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Nuvista Pharmaceuticals is 36AAFCN5519F1ZH, registered in Telangana.

The CIN (Corporate Identification Number) of Nuvista Pharmaceuticals is U24304TG2017PTC115996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nuvista Pharmaceuticals has 3 court cases on record: 3 filed against it. 3 are pending.

Nuvista Pharmaceuticals was incorporated on 20 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.

Sudhakara Reddy Kalakota was appointed as Director on 17 Sep 2021. Manjula Kotha ceased to be Director on 31 Mar 2019. Saira Siddiqui ceased to be Director on 28 Jul 2018. Nuvista Pharmaceuticals has 7 board changes on record in total.

Nuvista Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 60 overdue payments to 14 micro and small suppliers. The latest return was filed on 08 Jun 2019.

The registered office of Nuvista Pharmaceuticals is at Shed No 48 Phase II Ida Mallapur, Hyderabad, Telangana, India – 500076.

Nuvista Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.